Mindfulness-Based Cognitive Therapy Beneficial in Diabetes

Share this article:
Mindfulness-Based Cognitive Therapy Beneficial in Diabetes
Mindfulness-Based Cognitive Therapy Beneficial in Diabetes

For patients with diabetes and low levels of emotional well-being, mindfulness-based cognitive therapy (MBCT) improves emotional distress and health-related quality of life, according to a study published online in Diabetes Care.

To examine the effect of MBCT on emotional distress, health-related quality of life, and glycemic control, Jenny van Son, MSc, of Tilburg University in the Netherlands, and colleagues conducted a randomized controlled trial of 139 outpatients with type 1 or 2 diabetes and low levels of emotional well-being who received either MBCT (70 patients) or a waiting list (69 patients). At baseline and four and eight weeks of follow-up, assessments were conducted.

MBCT was significantly more effective at decreasing stress, depressive symptoms, and anxiety. MBCT also correlated with significantly improved physical and mental quality of life. MBCT had no significant effect on glycemic control, but patients with elevated diabetes distress had a trend toward reduced diabetes distress in the MBCT versus the control group.

"To the best of our knowledge, this is the first randomized trial to find immediate effects of a mindfulness-based intervention on emotional well-being and quality of life in outpatients with type 1 and type 2 diabetes," van Son and colleagues conclude.

Share this article:
You must be a registered member of RUN to post a comment.

More in Diabetes

Statins Provide Microvascular Benefit for Diabetics

Statins Provide Microvascular Benefit for Diabetics

Statin users with diabetes at lower risk of neuropathy, retinopathy, gangrene.

Prognostic Model Developed for Major Diabetes Outcomes

Prognostic Model Developed for Major Diabetes Outcomes

Model has adequate discrimination; has been validated in three independent cohorts.

New Assay Helps Diagnose Type 1 Diabetes

New Assay Helps Diagnose Type 1 Diabetes

But negative result from Kronus ZnT8Ab Elisa Assay doesn't rule out disease, FDA warns.